Metabolic Syndrome Increases Parkinson’s Disease Risk: Implications for Clinical Practice and Prevention
Highlight
- Individuals with metabolic syndrome have a 39% increased risk of developing Parkinson’s disease (PD) compared to those without the syndrome.
- Genetic predisposition amplifies PD risk in patients with metabolic syndrome, with nearly double the risk observed in high-risk genotypes.
- The PD risk increases in a dose-dependent manner according to the number of metabolic risk factors present.
- Findings emphasize the potential of lifestyle interventions targeting metabolic health to reduce PD risk, even for genetically predisposed individuals.
Study Background and Disease Burden
MedXY registered readers
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.